News & Trends - MedTech & Diagnostics
Philips’ global leader tackles barriers and ethical dilemmas in environmental sustainability
ESG: With the healthcare sector’s climate resilience and sustainability efforts varying widely across Australia, Senior Director of Group Sustainability at Philips, Olesya Struk, outlined a compelling blueprint for embedding environmental sustainability at the core of medtech companies.
Addressing the urgency felt by 60% of Australian consumers (Philips Future Health Index report) for sustainable healthcare delivery, Struk identified the biggest barriers to future-proofing health systems with environmental considerations.
“From the policy perspective, one of the biggest barriers lies in the need for clear regulatory frameworks and incentives that prioritise sustainability within the healthcare sector. The lack of standardisation across the healthcare industry is another top barrier to implementing environmental sustainability practices,” she emphasised in this Health Industry Hub podcast.
In response to the assertion from Kylie Woolcock, CEO of the Australian Healthcare and Hospitals Association (AHHA), that 40% of healthcare delivery is low-value care, waste or care that leads to harm, Struk acknowledged the role of medtech companies in promoting the concept of “doing less” to reduce emissions. She highlighted how Philips’ “digital solutions support dematerialisation by delivering maximum value with minimum materials, helping avoid unnecessary use of resources”.
Associate Professor Angie Bone from Monash Sustainable Development Institute challenged healthcare organisations by questioning whether they “value money over people and the planet”.
Reflecting on this powerful subject, Struk said it raised “fundamental ethical consideration within the healthcare sector and in the industry”. She shared her observations and addressed the broader industry view, saying “There is a growing recognition of the need to balance financial viability with social and environmental responsibility.”
Finally, she offered advice to medtech companies embarking on their sustainability journey, stressing how to “prioritise sustainability as strategic imperative”.
In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News & Trends - Pharmaceuticals
Government inaction on mental illness faces overwhelming criticism ahead of federal election
Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]
MoreNews & Trends - Pharmaceuticals
New CVD model marks a critical step in the right direction
Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]
MoreNews & Trends - Pharmaceuticals
Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation
Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]
MoreLeadership & Management
J&J MedTech appoints new ANZ leader
Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]
More